Loss of Fragile Histidine Triad Gene Expression in Advanced Lung Cancer Is Consequent to Allelic Loss at 3p14 Locus and Promoter Methylation
Loss of Fragile Histidine Triad Gene Expression in Advanced Lung Cancer Is Consequent to Allelic Loss at 3p14 Locus and Promoter Methylation
复制标题
晚期肺癌中脆性组氨酸三联体基因表达的丧失是 3p14 位点和启动子甲基化等位基因丢失的结果
作者:
Anjilna Wali;R. Srinivasan;Mir Snober Shabnam;S. Majumdar;K. Joshi;D. Behera
The fragile histidine triad (FHIT) gene located at the 3p14.2 locus plays an important role in the pathogenesis of lung cancer. The objective of this study was to analyze loss of heterozygosity and FHIT gene methylation status and correlate them to fhit expression. Bronchoscopically obtained lung biopsies from 30 cases of histologically proven carcinoma of the lung in stage III were assessed for the alterations in the FHIT gene. Fhit protein expression was determined by immunohistochemistry, and transcript levels were determined by reverse transcription-PCR. Microsattelite alterations and methylation status of the Fhit gene promoter was determined by PCR. Loss of heterozygosity at the 3p14 locus was observed in all the 30 cases at least by one of the three microsatellite polymorphic markers. The FHIT gene promoter showed complete methylation in 37% cases and partial methylation in 47% cases, and 16% cases showed no promoter methylation. FHIT full-length coding region (exons 5-9) transcripts were present in eight cases (26.6%), and aberrant transcripts were additionally seen in four cases. Loss of FHIT mRNA expression correlated to FHIT promoter methylation but not to loss of heterozygosity at the 3p14 locus. There was a strong correlation between the expression of FHIT at the transcript and protein level. The apoptotic index estimated by the terminal deoxynucleotidyl transferase–mediated nick end labeling assay was significantly correlated to the fhit protein expression. The results of this study indicate that in locally advanced carcinoma of the lung, there is frequent loss of FHIT expression, and methylation of the FHIT gene promoter is an important mechanism of its inactivation. (Mol Cancer Res 2006;4(2):93–9)
登录
查看更多内容
DOI:
10.1073/pnas.93.18.9821
发表时间:
1996-09-03
影响因子:
11.1
作者:
Herman, JG;Graff, JR;Baylin, SB
通讯作者:
Baylin, SB
影响因子:
11.2
作者:
Shridhar,V;Siegfried,J;Hunt,J;delMarAlonso,M;Smith,DI
通讯作者:
Smith,DI
DOI:
10.1016/s0169-5002(97)80271-1
发表时间:
1997-08
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
I. Wistuba;S. Lam;C. Behrens;A. Virmani;K. Fong;J. Leriche;J. Samet;S. Srivastava;J. Minna;A. Gazdar
通讯作者:
I. Wistuba;S. Lam;C. Behrens;A. Virmani;K. Fong;J. Leriche;J. Samet;S. Srivastava;J. Minna;A. Gazdar
影响因子:
11.2
作者:
Kastury,K;Baffa,R;Druck,T;Ohta,M;Cotticelli,MG;Inoue,H;Negrini,M;Rugge,M;Huang,D;Croce,CM;Palazzo,J;Huebner,K
通讯作者:
Huebner,K
影响因子:
2.9
作者:
Barnes, LD;Garrison, PN;Huebner, F
通讯作者:
Huebner, F